Pharmaceutical Grade Phospholipid Market Report: Trends, Forecast and Competitive Analysis to 2030
상품코드:1538448
리서치사:Lucintel
발행일:2024년 07월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
의약품 등급 인지질 동향 및 전망
세계 의약품 등급 인지질 시장은 2024년부터 2030년까지 연평균 4.4%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 지질 기반 약물전달 시스템에 대한 수요 증가, 제약 제제에서 인지질 채택 증가, 의약품의 생체 이용률 및 약물 안정성에 대한 관심 증가입니다. 세계 의약품 등급 인지질 시장의 미래는 제약 및 의료 시장에서의 기회로 인해 유망할 것으로 예상됩니다.
부문별 의약품 등급 인지질
이 조사에는 전 세계 의약품 등급 인지질에 대한 유형별, 용도별, 지역별 예측이 포함되어 있습니다.
의약품 등급 인지질 시장 인사이트
Lucintel의 예측에 따르면, 천연 인지질은 더 높은 성장을 이룰 것으로 예상됩니다.
이 시장에서는 의약품이 더 높은 성장세를 보일 것으로 예상됩니다.
아시아태평양이 가장 높은 성장세를 보일 것으로 예상됩니다.
자주 묻는 질문
Q1. 시장 성장 예측은?
A1. 의약품 등급 인지질 세계 시장은 2024년부터 2030년까지 연평균 4.4%의 성장률을 보일 것으로 예상됩니다.
Q2. 시장 성장에 영향을 미치는 주요 촉진요인은?
A2. 이 시장의 주요 촉진요인은 지질 기반 약물전달 시스템에 대한 수요 증가, 의약품 제제에서 인지질 채택 증가, 의약품의 생체 이용률 및 약물 안정성에 대한 관심 증가입니다.
Q3. 시장의 주요 부문은?
A3. 제약 및 의료 시장에서의 기회로 인해 의약품 등급 인지질 시장의 미래가 유망합니다.
Q4. 시장의 주요 기업은?
A4. 의약품 등급 인지질의 주요 기업은 다음과 같습니다.
Cargill Incorporated
Avril
Sime Darby Oils
Croda Pharma
Nippon Fine Chemical
Nof Corporation
Suzhou Fushilai Pharmaceutical
LIPOID
Louis Dreyfus Company
Shenyang Tianfeng Bio-Pharm
Q5. 향후 가장 큰 시장 부문은?
A5. Lucintel은 천연 인지질이 더 높은 성장을 이룰 것으로 예측하고 있습니다.
Q6. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은?
A6. 아시아태평양이 가장 높은 성장세를 보일 것으로 예상됩니다.
Q7. 보고서 사용자 정의가 가능합니까?
A7. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.
목차
제1장 주요 요약
제2장 세계의 의약품 등급 인지질 시장 : 시장 역학
소개, 배경, 분류
공급망
업계 성장 촉진요인과 과제
제3장 2018년부터 2030년까지 시장 동향과 예측 분석
거시경제 동향(2018-2023년)과 예측(2024-2030년)
세계의 의약품 등급 인지질 시장 동향(2018-2023년)과 예측(2024-2030년)
세계의 의약품 등급 인지질 시장(유형별)
천연 인지질
합성 인지질
용도별 세계의 의약품 등급 인지질 시장
의약품
의료
기타
제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석
지역별 세계의 의약품 등급 인지질 시장
북미의 의약품 등급 인지질 시장
유럽의 의약품 등급 인지질 시장
아시아태평양의 의약품 등급 인지질 시장
기타 지역의 의약품 등급 인지질 시장
제5장 경쟁 분석
제품 포트폴리오 분석
업무 통합
Porter's Five Forces 분석
제6장 성장 기회와 전략 분석
성장 기회 분석
세계의 의약품 등급 인지질 시장의 성장 기회(유형별)
용도별 세계의 의약품 등급 인지질 시장 성장 기회
지역별 세계의 의약품 등급 인지질 시장 성장 기회
세계의 의약품 등급 인지질 시장 최신 동향
전략 분석
신제품 개발
세계의 의약품 등급 인지질 시장 생산능력 확대
세계의 의약품 등급 인지질 시장 합병, 인수, 합작투자
인증과 라이선싱
제7장 주요 기업 개요
Cargill Incorporated
Avril
Sime Darby Oils
Croda Pharma
Nippon Fine Chemical
Nof Corporation
Suzhou Fushilai Pharmaceutical
LIPOID
Louis Dreyfus Company
Shenyang Tianfeng Bio-Pharm
ksm
영문 목차
영문목차
Pharmaceutical Grade Phospholipid Trends and Forecast
The future of the global pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets. The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pharmaceutical Grade Phospholipid by Segment
The study includes a forecast for the global pharmaceutical grade phospholipid by type, application, and region.
Pharmaceutical Grade Phospholipid Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Natural Phospholipids
Synthetic Phospholipids
Pharmaceutical Grade Phospholipid Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Pharmaceuticals
Healthcare
Others
Pharmaceutical Grade Phospholipid Market by Region [Shipment Analysis by Value from 2018 to 2030]:
North America
Europe
Asia Pacific
The Rest of the World
List of Pharmaceutical Grade Phospholipid Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical grade phospholipid companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical grade phospholipid companies profiled in this report include-
Cargill Incorporated
Avril
Sime Darby Oils
Croda Pharma
Nippon Fine Chemical
Nof Corporation
Suzhou Fushilai Pharmaceutical
LIPOID
Louis Dreyfus Company
Shenyang Tianfeng Bio-Pharm
Pharmaceutical Grade Phospholipid Market Insights
Lucintel forecasts that natural phospholipid is expected to witness higher growth.
Within this market, pharmaceutical is expected to witness higher growth.
APAC is expected to witness the highest growth.
Features of the Global Pharmaceutical Grade Phospholipid Market
Market Size Estimates: Pharmaceutical grade phospholipid market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pharmaceutical grade phospholipid market size by type, application, and region in terms of value ($B).
Regional Analysis: Pharmaceutical grade phospholipid market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the pharmaceutical grade phospholipid market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pharmaceutical grade phospholipid market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the growth forecast for pharmaceutical grade phospholipid market?
Answer: The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the pharmaceutical grade phospholipid market?
Answer: The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.
Q3. What are the major segments for pharmaceutical grade phospholipid market?
Answer: The future of the pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets.
Q4. Who are the key pharmaceutical grade phospholipid market companies?
Answer: Some of the key pharmaceutical grade phospholipid companies are as follows:
Cargill Incorporated
Avril
Sime Darby Oils
Croda Pharma
Nippon Fine Chemical
Nof Corporation
Suzhou Fushilai Pharmaceutical
LIPOID
Louis Dreyfus Company
Shenyang Tianfeng Bio-Pharm
Q5. Which pharmaceutical grade phospholipid market segment will be the largest in future?
Answer: Lucintel forecasts that natural phospholipid is expected to witness higher growth.
Q6. In pharmaceutical grade phospholipid market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical grade phospholipid market by type (natural phospholipids and synthetic phospholipids), application (pharmaceuticals, healthcare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Pharmaceutical Grade Phospholipid Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pharmaceutical Grade Phospholipid Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pharmaceutical Grade Phospholipid Market by Type
3.3.1: Natural Phospholipids
3.3.2: Synthetic Phospholipids
3.4: Global Pharmaceutical Grade Phospholipid Market by Application
3.4.1: Pharmaceuticals
3.4.2: Healthcare
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pharmaceutical Grade Phospholipid Market by Region
4.2: North American Pharmaceutical Grade Phospholipid Market
4.2.1: North American Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
4.2.2: North American Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
4.3: European Pharmaceutical Grade Phospholipid Market
4.3.1: European Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
4.3.2: European Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
